0001209191-22-042039.txt : 20220713 0001209191-22-042039.hdr.sgml : 20220713 20220713160552 ACCESSION NUMBER: 0001209191-22-042039 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220711 FILED AS OF DATE: 20220713 DATE AS OF CHANGE: 20220713 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ramasastry Saira CENTRAL INDEX KEY: 0001547959 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39083 FILM NUMBER: 221081143 MAIL ADDRESS: STREET 1: 501 CANAL BLVD. CITY: RICHMOND STATE: CA ZIP: 94804 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vir Biotechnology, Inc. CENTRAL INDEX KEY: 0001706431 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812730369 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 BUSINESS PHONE: 415-906-4324 MAIL ADDRESS: STREET 1: 499 ILLINOIS STREET STREET 2: SUITE 500 CITY: SAN FRANCISCO STATE: CA ZIP: 94158 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-11 0 0001706431 Vir Biotechnology, Inc. VIR 0001547959 Ramasastry Saira C/O VIR BIOTECHNOLOGY, INC. 499 ILLINOIS STREET, STE 500 SAN FRANCISCO CA 94158 1 0 0 0 Common Stock 2022-07-11 4 A 0 5000 12.76 A 13092 D Common Stock 2022-07-11 4 S 0 5000 30.00 D 8092 D Stock Option (Right to Buy) 12.76 2022-07-11 4 M 0 5000 0.00 D 2029-12-09 Common Stock 5000 42777 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022. 1/3 of the shares subject to the stock option vested and became exercisable on September 4, 2020, and the remaining shares vest in 24 equal monthly installments thereafter. /s/ Howard Horn, Attorney-in-Fact 2022-07-12